Copy Link Print Information

L-DOPA sodium

(別名: Levodopa sodium; 3,4-Dihydroxyphenylalanine sodium)
35 Cited Publications
カスタマーレビュー

Based on 35 publication(s) in Google Scholar

L-DOPA (Levodopa) sodium is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA sodium can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA sodium has anti-allodynic effects, and can be used for Parkinson's disease research.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

  • 純度: 99.95%
  • CAS 番号: 63302-01-2
  • 分子式: C9H10NNaO4
  • 分子量:219.17
  • 保管条件:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • L-DOPA sodium Chemical Structure
    L-DOPA sodium 構造式
  • Experimental Validation Results for L-DOPA sodium
  • Experimental Validation Results for L-DOPA sodium
  • Experimental Validation Results for L-DOPA sodium
  • Experimental Validation Results for L-DOPA sodium
  • Experimental Validation Results for L-DOPA sodium
CAS 番号: 63302-01-2
容量
価格（税別）
在庫状況
数量
Amount: USD 0.00
Please select quantity
or
or

* アイテムを追加する前、数量をご選択ください

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of L-DOPA sodium:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
最寄りの代理店をお探しください Your local distributor: Hycultec GmbHHycultec
  • 生物活性
  • 化学情報
  • 純度とドキュメンテーション
  • 参考文献
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

MedChemExpress（MCE）の使用を引用している文献 L-DOPA sodium

More
Customer Validation & Images
WBIn Vivo Efficacy StudyIHC
  • In Vivo Efficacy Study
  • In Vivo Efficacy Study
  • IHC
  • In Vivo Efficacy Study
  • WB

Dopamine Receptor アイソフォーム固有の製品をすべて表示

More

Endogenous Metabolite アイソフォーム固有の製品をすべて表示

More
Keywords
MOQ
Minimum order quantity
100 mg

お問い合わせ 在庫あり

Other size
お問い合わせ
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress ログイン
Register
Sign in to MedChemExpress
新規会員登録

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • L-DOPA sodium Chemical Structure
    L-DOPA sodium Chemical Structure
    1/16
  • 1/16

    L-DOPA sodium purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 May;12(20):e2413376. [Abstract]

    Customer Validation
     Behavior analysis of pole test, rotarod test, suspension test, and forced swimming test after administration of L-DOPA, NanoMassage or saline. Mice were given an oral administration of 20 mg/kg L-DOPA on 4th day of MPTP administration and sacrificed on the 8th day.

  • 1/16

    L-DOPA sodium purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Oct;11(39):e2403058. [Abstract]

    Customer Validation
     Movement track and total distance travelled in the open field test, descent time in the pole test and time-to-fall in the rotarod test. Mice in the treatment groups intragastrically (i.g.) administered 20 mg/kg/d L-DOPA for 27 days.

  • 1/16

    L-DOPA sodium purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Oct;11(39):e2403058. [Abstract]

    Customer Validation
     Immunohistochemical staining of TH+ neurons. Mice in the treatment groups intragastrically (i.g.) administered 20 mg/kg/d L-DOPA for 27 days.

  • 1/16

    L-DOPA sodium purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2024 Oct;11(39):e2403058. [Abstract]

    Customer Validation
     Quantification of TH+ neurons. Mice in the treatment groups intragastrically (i.g.) administered 20 mg/kg/d L-DOPA for 27 days.

  • 1/16

    L-DOPA sodium purchased from MedChemExpress. Usage Cited in: CNS Neurosci Ther. 2023 Oct;29(10):2925-2939. [Abstract]

    Customer Validation
     Amphiregulin (Areg) is highly expressed in the levodopa‐induced dyskinesia 6‐OHDA (4 μg; 4 weeks) Parkinson's disease mouse model. The Parkinson's disease group treated with a daily 12 mg/kg of levodopa for 15 days developed dyskinetic movement. On western blotting, this group further showed a significant increase of Amphiregulin protein expression relative to the Parkinson's disease group injected with normal saline only .

  • L-DOPA sodium